BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18547465)

  • 1. Psychosocial impact and effectiveness of tadalafil among treatment-naïve and previously-treated men with erectile dysfunction in Saudi Arabia and other Gulf-region countries.
    El Khiat Y; Ghazi S; Allam A; Khawaja M; Belger M; Tamer M; Kopernicky V
    Curr Med Res Opin; 2008 Jul; 24(7):1965-73. PubMed ID: 18547465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US.
    Goldstein I; Kim E; Steers WD; Pryor JL; Wilde DW; Natanegara F; Wong DG; Ahuja S
    J Sex Med; 2007 Jan; 4(1):166-175. PubMed ID: 17233782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychosocial outcomes after initial treatment of erectile dysfunction with tadalafil once daily, tadalafil on demand or sildenafil citrate on demand: results from a randomized, open-label study.
    Hatzimouratidis K; Buvat J; Büttner H; Vendeira PA; Moncada I; Boehmer M; Henneges C; Boess FG
    Int J Impot Res; 2014; 26(6):223-9. PubMed ID: 24784894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tadalafil is efficacious in Black American and Hispanic men with erectile dysfunction: results from multiple observations in men with erectile dysfunction in national tadalafil study in the US (MOMENTUS).
    Gomery P; Bullock A; McGettigan J; Munarriz R; Natanegara F; Hague J; Kuepfer C; Ahuja S; Wong D
    Int J Impot Res; 2007; 19(1):76-83. PubMed ID: 16728966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open-label, crossover study.
    Eardley I; Montorsi F; Jackson G; Mirone V; Chan ML; Loughney K; Vail GM; Beardsworth A
    BJU Int; 2007 Jul; 100(1):122-9. PubMed ID: 17552960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of tadalafil in clinical populations.
    Lewis RW; Sadovsky R; Eardley I; O'Leary M; Seftel A; Wang WC; Shen W; Walker DJ; Wong DG; Ahuja S
    J Sex Med; 2005 Jul; 2(4):517-31. PubMed ID: 16422847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States.
    Sharlip ID; Shumaker BP; Hakim LS; Goldfischer E; Natanegara F; Wong DG
    J Sex Med; 2008 Mar; 5(3):716-25. PubMed ID: 18304286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury.
    Giuliano F; Sanchez-Ramos A; Löchner-Ernst D; Del Popolo G; Cruz N; Leriche A; Lombardi G; Reichert S; Dahl P; Elion-Mboussa A; Casariego J
    Arch Neurol; 2007 Nov; 64(11):1584-92. PubMed ID: 17846260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized open-label trial with a crossover comparison of sexual self-confidence and other treatment outcomes following tadalafil once a day vs. tadalafil or sildenafil on-demand in men with erectile dysfunction.
    Rubio-Aurioles E; Porst H; Kim ED; Montorsi F; Hackett G; Morales AM; Stuckey B; Būttner H; West TM; Huynh NN; Lenero E; Burns P; Kopernicky V
    J Sex Med; 2012 May; 9(5):1418-29. PubMed ID: 22429760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosocial outcomes and drug attributes affecting treatment choice in men receiving sildenafil citrate and tadalafil for the treatment of erectile dysfunction: results of a multicenter, randomized, open-label, crossover study.
    Dean J; Hackett GI; Gentile V; Pirozzi-Farina F; Rosen RC; Zhao Y; Warner MR; Beardsworth A
    J Sex Med; 2006 Jul; 3(4):650-661. PubMed ID: 16839321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tadalafil in the treatment of Latin American men with erectile dysfunction: results of integrated analyses.
    Rubio-Aurioles E; Casabé A; Torres LO; Quinzaños L; Glina S; Filimon I; Kopernicky V; Leñero E
    J Sex Med; 2008 Aug; 5(8):1965-76. PubMed ID: 18466266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil.
    McMahon C
    J Sex Med; 2004 Nov; 1(3):292-300. PubMed ID: 16422959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of the psychological and interpersonal relationship scales to oral therapies for erectile dysfunction.
    Rosen R; Broderick G; Shabsigh R; Swindle R; Lockhart D; Cameron A
    J Sex Med; 2005 Jul; 2(4):461-8. PubMed ID: 16422840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers.
    Carson C; Shabsigh R; Segal S; Murphy A; Fredlund P; Kuepfer C;
    Urology; 2005 Feb; 65(2):353-9. PubMed ID: 15708052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the efficacy and tolerability of tadalafil 10 mg and 20 mg in Japanese patients with severe erectile dysfunction.
    Marumo K; Imaoka T; Fujimoto K; Watts S; Stothard D; McGill J
    J Sex Med; 2007 May; 4(3):745-752. PubMed ID: 17087800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy.
    Eardley I; Mirone V; Montorsi F; Ralph D; Kell P; Warner MR; Zhao Y; Beardsworth A
    BJU Int; 2005 Dec; 96(9):1323-32. PubMed ID: 16287454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvements in confidence, sexual relationship and satisfaction measures: results of a randomized trial of tadalafil 5 mg taken once daily.
    Seftel AD; Buvat J; Althof SE; McMurray JG; Zeigler HL; Burns PR; Wong DG
    Int J Impot Res; 2009; 21(4):240-8. PubMed ID: 19536128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial.
    Carrier S; Brock GB; Pommerville PJ; Shin J; Anglin G; Whitaker S; Beasley CM
    J Sex Med; 2005 Sep; 2(5):685-98. PubMed ID: 16422827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.